Morgantown, PA, United States of America

James Bradford Kline

USPTO Granted Patents = 5 

 

 

Average Co-Inventor Count = 2.9

ph-index = 1

Forward Citations = 31(Granted Patents)


Location History:

  • Grove City, PA (US) (1994)
  • Morgantown, PA (US) (2015 - 2021)

Company Filing History:


Years Active: 1994-2021

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of James Bradford Kline

Introduction

James Bradford Kline is a notable inventor based in Morgantown, PA (US). He has made significant contributions to the field of immunology, holding a total of five patents. His work focuses on the development of conjugated immunoglobulins, which have important applications in therapeutic and diagnostic settings.

Latest Patents

Kline's latest patents include methods for generating Cys80 conjugated immunoglobulins. These methods involve decapping a cysteine at amino acid position 80 in a light chain variable region of an immunoglobulin. The immunoglobulin comprises both a heavy chain variable region and the light chain variable region. The process includes conjugating a thiol-reactive compound to the Cys80, which contains a thiol-reactive group. Additionally, Kline's patents cover antigen-binding molecules, methods for generating immunoglobulins, nucleic acid molecules encoding these immunoglobulins, and host cells that comprise the nucleic acid molecules.

Career Highlights

Throughout his career, Kline has worked with various organizations, including Eisai R&D Management Co., Ltd. His innovative work has contributed to advancements in the field of immunology and has been recognized by his peers.

Collaborations

Kline has collaborated with notable coworkers such as Luigi Grasso and Jared Spidel. These collaborations have further enhanced the impact of his research and inventions.

Conclusion

James Bradford Kline's contributions to the field of immunology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…